PharmaShots | Incisive News in 3 Shots

Subscribe Now

sell

Cardinal Health to Divest its Cordis Business to Hellman & Friedman for $1B

Cardinal Health to Divest its Cordis Business to Hellman & Friedman for $1B

March 15, 2021

Servier to Acquire Agios' Oncology Business for ~$2B

Servier to Acquire Agios' Oncology Business for ~$2B

December 22, 2020

Boston Scientific to Divest BTG's Specialty Pharma Business for ~$800M

Boston Scientific to Divest BTG's Specialty Pharma Business for ~$800M

December 2, 2020

CoSara Receives CDSCO's Approval for its Saragene COVID-19 2-Gene Multiplex Test

CoSara Receives CDSCO's Approval for its Saragene COVID-19 2-Gene Multiplex Test

November 27, 2020

AstraZeneca to Sell Commercialization Rights of its Two Oncology Candidates to Juvise Pharmaceuticals

AstraZeneca to Sell Commercialization Rights of its Two Oncology Candidates to Juvise Pharmaceuticals

December 20, 2019

Eli Lilly to Sell Rights for its Two Antibiotics and a Manufacturing Facility to Eddingpharm in China for $375M

Eli Lilly to Sell Rights for its Two Antibiotics and a Manufacturing Facility to Eddingpharm in China for $375M

April 23, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us